Literature DB >> 3097864

Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis.

H Gilljam, A S Malmborg, B Strandvik.   

Abstract

The use of sputum cultures to guide the antimicrobial treatment of patients with cystic fibrosis has been questioned. Bacterial growth and antibiotic susceptibility patterns of 33 culture pairs from sputum and contamination free endobronchial swabs from 14 patients with cystic fibrosis were compared. As expected, Pseudomonas aeruginosa of the mucoid and non-mucoid type, Staphylococcus aureus, and Haemophilus influenzae were the organisms most frequently found. Absolute or good agreement was found in 73% of the culture pairs. The accuracy of the sputum cultures improved with the duration of antimicrobial treatment. The extra information gained from the endobronchial culture did not change the antimicrobial strategy from that based on the sputum culture alone. It is concluded that sputum cultures provide accurate information about the bacterial colonisation of the lower respiratory tract in patients with cystic fibrosis and therefore can be trusted both at onset of treatment and during the entire treatment period.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097864      PMCID: PMC460411          DOI: 10.1136/thx.41.8.641

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates.

Authors:  J G Bartlett; S M Finegold
Journal:  Am Rev Respir Dis       Date:  1978-06

3.  Usefulness of transtracheal puncture in the bacteriological diagnosis of lung infections in children.

Authors:  D Baran; N Cordier
Journal:  Helv Paediatr Acta       Date:  1973-11

4.  Partial preservation of pancreatic beta-cell function in children with diabetes.

Authors:  R B Elliott; J R Crossley; C C Berryman; A G James
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

5.  Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection.

Authors:  D E Roberts; P Cole
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

6.  Etiological diagnosis of bacterial pneumonia by gram stain and quantitative culture of expectorates. Leukocytes or alveolar macrophages as indicators of sample representativity.

Authors:  M Kalin; A A Lindberg; G Tunevall
Journal:  Scand J Infect Dis       Date:  1983

7.  Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.

Authors:  M J Thomassen; C A Demko; B Boxerbaum; R C Stern; P J Kuchenbrod
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

8.  Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis.

Authors:  M J Thomassen; J D Klinger; S J Badger; D W van Heeckeren; R C Stern
Journal:  J Pediatr       Date:  1984-03       Impact factor: 4.406

9.  Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

Authors:  P H Beaudry; M I Marks; D McDougall; K Desmond; R Rangel
Journal:  J Pediatr       Date:  1980-07       Impact factor: 4.406

10.  Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.

Authors:  B Strandvik; A S Malmborg; H Alfredson; A Ericsson
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

  10 in total
  12 in total

Review 1.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Utility of gram stain in evaluation of sputa from patients with cystic fibrosis.

Authors:  E Sadeghi; A Matlow; I MacLusky; M A Karmali
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

3.  Sputum induction improves detection of pathogens in children with cystic fibrosis.

Authors:  Jordana E Hoppe; Elinor Towler; Brandie D Wagner; Frank J Accurso; Scott D Sagel; Edith T Zemanick
Journal:  Pediatr Pulmonol       Date:  2015-01-07

4.  characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.

Authors:  G B Rogers; M P Carroll; D J Serisier; P M Hockey; G Jones; K D Bruce
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 5.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

6.  Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population.

Authors:  F Karpati; A S Malmborg; H Alfredsson; L Hjelte; B Strandvik
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

7.  Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling.

Authors:  G B Rogers; C A Hart; J R Mason; M Hughes; M J Walshaw; K D Bruce
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 8.  Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset.

Authors:  Geraint B Rogers; Lucas R Hoffman; Matt W Johnson; Nicole Mayer-Hamblett; Jürgen Schwarze; Mary P Carroll; Kenneth D Bruce
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

9.  Potential of anti-inflammatory treatment for cystic fibrosis lung disease.

Authors:  Jennifer L Taylor-Cousar; Kelsey A Von Kessel; Robert Young; David P Nichols
Journal:  J Inflamm Res       Date:  2010-08-10

10.  Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.

Authors:  A E Hollsing; M Granström; M L Vasil; B Wretlind; B Strandvik
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 11.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.